MX9705856A - Uso de melatonina en la fabricacion de un medicamento para tratar la adiccion a las drogas. - Google Patents
Uso de melatonina en la fabricacion de un medicamento para tratar la adiccion a las drogas.Info
- Publication number
- MX9705856A MX9705856A MX9705856A MX9705856A MX9705856A MX 9705856 A MX9705856 A MX 9705856A MX 9705856 A MX9705856 A MX 9705856A MX 9705856 A MX9705856 A MX 9705856A MX 9705856 A MX9705856 A MX 9705856A
- Authority
- MX
- Mexico
- Prior art keywords
- melatonin
- benzodiazepine drug
- patient
- patients suffering
- treating patients
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Anesthesiology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La melatonina se usa en la fabricacion de un medicamento para tratar un adicto a multiples drogas o un paciente que tenga los síntomas de haberse vuelto dependiente de, tolerante a, o adicto a un fármaco de benzodiazepina, o para tratar un paciente que haya sido diagnosticado clínicamente con una condicion susceptible al alivio mediante la administracion de un fármaco de benzodiazepina, evitando simultáneamente la ocurrencia en el paciente de síntomas de dependencia de, tolerancia a, o adicion a dicho fármaco de benzodiazepina; la invencion se refiere además a una formulacion farmacéutica para los propositos anteriormente mencionados, la cual comprende por lo menos un diluyente, vehículo a adyuvante y como ingredientes activos un fármaco de benzodiazepina y melatonina.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08381535 | 1995-02-01 | ||
| US08/381,535 US6469044B1 (en) | 1995-02-01 | 1995-02-01 | Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies |
| EP95303853A EP0724878B1 (en) | 1995-02-01 | 1995-06-06 | Use of melatonin for treating patients suffering from drug dependencies |
| EP95303853 | 1995-06-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9705856A true MX9705856A (es) | 1998-07-31 |
| MXPA97005856A MXPA97005856A (es) | 1998-11-09 |
Family
ID=
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Merskey et al. | The treatment of chronic pain with psychotropic drugs | |
| Dujovne et al. | Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin | |
| IE893690L (en) | Treatment of obesity | |
| IL121160A0 (en) | Method compositions and kits for increasing the oral bioavailability of pharmaceutical agents | |
| WO2005065069A3 (en) | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease | |
| NO306457B1 (no) | 2,4-disulfonylfenylbutylnitron, salter derav, farmasöytisk sammensetning, samt anvendelse av denne forbindelse til fremstilling av et medikament | |
| CZ176595A3 (en) | The application of anticonvulsive agents for the preparation of medicaments intended for treating parkinson's disease and parkinson's syndromes | |
| US5147872A (en) | Treatment of immunologically based disorders, specifically psoriasis | |
| ES2139842T3 (es) | Uso de la melatonina para tratar a pacientes que sufren drogodependencia. | |
| AU746211B2 (en) | Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor | |
| BG101803A (en) | Use of melatonin for treating patients suffering from drug addiction | |
| US5017575A (en) | Treatment of immunologically based disorders, specifically Crohn's disease | |
| JPH09504798A (ja) | 早発性射精の治療におけるアルフゾシンまたはテラゾシンの使用 | |
| WO1996023496B1 (en) | Use of melatonin for treating patients suffering from drug addiction | |
| KR100420673B1 (ko) | 지연된구토반응을치료하기위한비강투여제 | |
| EP0204954B1 (en) | Use of dopamine agonists for the manufacture of a medicament for the treatment of psychostimulant addiction | |
| JPH01261334A (ja) | アンギオテンシン転換酵素阻害剤を有効成分とした医療用調剤及びその製造方法 | |
| Beutler et al. | Arthralgias and omeprazole. | |
| CA2211839A1 (en) | Use of melatonin for treating patients suffering from drug addiction | |
| Pearlstein et al. | Sumatriptan-associated myocardial infarction: report of case with attention to potential risk factors | |
| GB2248392A (en) | Composition to combat alcoholism | |
| Joy | Clonazepam: benzodiazepine therapy for the restless legs syndrome | |
| EE9700366A (et) | Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid | |
| Weddington et al. | Changes in Mood, Craving and | |
| Barrett | Anisocoria associated with selective serotonin reuptake inhibitors. |